aTyr Pharma, Inc.

NASDAQ:LIFE

1.9 (USD) • At close June 4, 2024
Bedrijfsnaam aTyr Pharma, Inc.
Symbool LIFE
Munteenheid USD
Prijs 1.9
Beurswaarde 131,120,702
Dividendpercentage 0%
52-weken bereik 1.08 - 2.45
Industrie Biotechnology
Sector Healthcare
CEO Dr. Sanjay S. Shukla M.D., M.S.
Website https://www.atyrpharma.com

An error occurred while fetching data.

Over aTyr Pharma, Inc.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical

Vergelijkbare Aandelen

Lipocine Inc. logo

Lipocine Inc.

LPCN

4.61 USD

Miromatrix Medical Inc. logo

Miromatrix Medical Inc.

MIRO

3.39 USD

Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc.

ASMB

18.07 USD

SAB Biotherapeutics, Inc. logo

SAB Biotherapeutics, Inc.

SABS

2.79 USD

Clearside Biomedical, Inc. logo

Clearside Biomedical, Inc.

CLSD

1.23 USD

Eliem Therapeutics, Inc. logo

Eliem Therapeutics, Inc.

ELYM

8.46 USD

Wave Life Sciences Ltd. logo

Wave Life Sciences Ltd.

WVE

5.86 USD

Homology Medicines, Inc. logo

Homology Medicines, Inc.

FIXX

0.935 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)